Clinical Research Coordinator (Research Institute)

McGill University Health Centre; Montreal; On-site; CAD 60,000 - 80,000; Full time

Job summary

A leading research institute in Montreal seeks a Research Coordinator to manage the Pancreatic Cancer Early Detection Consortium and the Quebec Pancreas Cancer Study. This role involves patient enrollment, biospecimen collection, and data management to enhance early detection and treatment of pancreatic cancer. Ideal candidates will have a background in clinical research, strong organizational skills, and experience in genetic counseling.

Qualifications

• Experience in clinical research and patient management.
• Strong organizational skills and attention to detail.
• Ability to work collaboratively in a research environment.

Responsibilities

• Manage patient enrollment and data entry for the PRECEDE Consortium.
• Oversee the QPCS research pancreatic cancer surveillance protocol.
• Coordinate genetic testing and study participation requirements.

Skills

Data management

Patient enrollment

Genetic counseling

Education

Bachelor's degree in a related field

Job description

RESEARCH INSTITUTE OF THE MUHC
The Research Institute of the McGill University Health Centre (RI-MUHC) is a world-renowned biomedical and hospital research centre. Located in Montreal, Quebec, the Institute is the research arm of the McGill University Health Centre (MUHC) affiliated with the Faculty of Medicine at McGill University. The RI-MUHC is supported in part by the Fonds de recherche du Québec - Santé (FRQS).

Position summary
The candidate will contribute to the Quebec Pancreas Cancer Study (QPCS) as well as affiliate consortia and clinical trial studies, including the PRECEDE Consortium. The QPCS was established in 2011 as a familial patient registry for pancreatic cancer and related clinical conditions. Clinic-based activities of the QPCS include genetic counseling and testing in real-time for patients with a pancreatic cancer diagnosis. The key research aims of the QPCS are to characterize the genetic susceptibility of pancreatic cancer, identify early detection biomarkers and modifiable risks factors for pancreatic cancer, and develop clinical surveillance protocols for individuals at high risk for developing pancreatic cancer. Pancreatic Cancer Early Detection (PRECEDE) Consortium is an international, multi-institutional collaborative group of experts to increase survival for pancreatic cancer patients by improving early detection, screening, risk modeling and prevention for those with a heritable risk for pancreatic cancer, through a novel model of collaboration and data sharing.

General Duties
• Managing the Pancreatic Cancer Early Detection (PRECEDE) Consortium at the MUHC site, including patient enrollment, biospecimen collection and data entry (66%),
• Managing the QPCS research pancreatic cancer surveillance protocol for high-risk individuals, including patient enrollment, biospecimen collection and data entry (34%),
• Prescreening to identify patients eligible to participate in the QPCS and its affiliate studies,
• Enrolment of eligible patients into the QPCS and its affiliate studies, including obtaining family histories and building pedigrees,
• Navigating patients through genetic testing and study participation requirements by scheduling and coordinating clinical research appointments, genetic testing and biospecimen collections,
• Completing participant enrolment by 1) obtaining authorization for medical records as well as access to archived biospecimens and 2) sending requests for medical records and/or archival biospecimen acquisitions,
• Data entry and management of online study databases,
• Assisting with returning of genetic testing results to patients and treating physicians.